Page last updated: 2024-10-29

ketamine and Chronic Pancreatitis

ketamine has been researched along with Chronic Pancreatitis in 2 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ertem, FU1
Eubanks, J1
Saul, M1
Kang, CR1
Emerick, T1
Yadav, D1
Juel, J1
Olesen, SS1
Olesen, AE1
Poulsen, JL1
Dahan, A1
Wilder-Smith, O1
Madzak, A1
Frøkjær, JB1
Drewes, AM1

Trials

1 trial available for ketamine and Chronic Pancreatitis

ArticleYear
Study protocol for a randomised, double-blinded, placebo-controlled, clinical trial of S-ketamine for pain treatment in patients with chronic pancreatitis (RESET trial).
    BMJ open, 2015, Mar-10, Volume: 5, Issue:3

    Topics: Administration, Oral; Analgesics; Analgesics, Opioid; Chronic Pain; Double-Blind Method; Humans; Hyp

2015

Other Studies

1 other study available for ketamine and Chronic Pancreatitis

ArticleYear
Ketamine infusion for pain management in hospitalized patients with Chronic Pancreatitis: A case series.
    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2023, Volume: 23, Issue:4

    Topics: Analgesics; Chronic Pain; Humans; Infusions, Intravenous; Ketamine; Pain; Pain Management; Pancreati

2023